Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Boutant 2016 Cell Rep"

From Bioblast
(Created page with "{{Publication |title=Boutant M, Kulkarni SS, Joffraud M, Raymond F, Métairon S, Descombes P, Cantó C (2016) SIRT1 gain of function does not mimic or enhance the adaptations to ...")
 
Line 1: Line 1:
{{Publication
{{Publication
|title=Boutant M, Kulkarni SS, Joffraud M, Raymond F, Métairon S, Descombes P, Cantó C (2016) SIRT1 gain of function does not mimic or enhance the adaptations to intermittent fasting. Cell Rep 14:2068-75.  
|title=Boutant M, Kulkarni SS, Joffraud M, Raymond F, Métairon S, Descombes P, Cantó C (2016) SIRT1 gain of function does not mimic or enhance the adaptations to intermittent fasting. Cell Rep 14:2068-75.
|info=[http://www.ncbi.nlm.nih.gov/pubmed/26923584 PMID: 26923584 Open Access]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/26923584 PMID: 26923584 Open Access]
|authors=Boutant M, Kulkarni SS, Joffraud M, Raymond F, Métairon S, Descombes P, Cantó C
|authors=Boutant M, Kulkarni SS, Joffraud M, Raymond F, Metairon S, Descombes P, Canto C
|year=2016
|year=2016
|journal=Cell Rep
|journal=Cell Rep
|abstract=Caloric restriction (CR) has been shown to prevent the onset of insulin resistance and to delay age-related physiological decline in mammalian organisms. SIRT1, a NAD(+)-dependent deacetylase enzyme, has been suggested to mediate the adaptive responses to CR, leading to the speculation that SIRT1 activation could be therapeutically used as a CR-mimetic strategy. Here, we used a mouse model of moderate SIRT1 overexpression to test whether SIRT1 gain of function could mimic or boost the metabolic benefits induced by every-other-day feeding (EODF). Our results indicate that SIRT1 transgenesis does not affect the ability of EODF to decrease adiposity and improve insulin sensitivity. Transcriptomic analyses revealed that SIRT1 transgenesis and EODF promote very distinct adaptations in individual tissues, some of which can be even be metabolically opposite, as in brown adipose tissue. Therefore, whereas SIRT1 overexpression and CR both improve glucose metabolism and insulin sensitivity, the etiologies of these benefits are largely different.
|abstract=Caloric restriction (CR) has been shown to prevent the onset of insulin resistance and to delay age-related physiological decline in mammalian organisms. SIRT1, a NAD(+)-dependent deacetylase enzyme, has been suggested to mediate the adaptive responses to CR, leading to the speculation that SIRT1 activation could be therapeutically used as a CR-mimetic strategy. Here, we used a mouse model of moderate SIRT1 overexpression to test whether SIRT1 gain of function could mimic or boost the metabolic benefits induced by every-other-day feeding (EODF). Our results indicate that SIRT1 transgenesis does not affect the ability of EODF to decrease adiposity and improve insulin sensitivity. Transcriptomic analyses revealed that SIRT1 transgenesis and EODF promote very distinct adaptations in individual tissues, some of which can even be metabolically opposite, as in brown adipose tissue. Therefore, whereas SIRT1 overexpression and CR both improve glucose metabolism and insulin sensitivity, the etiologies of these benefits are largely different.


Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
Line 11: Line 11:
}}
}}
{{Labeling
{{Labeling
|area=Respiration
|area=Respiration, nDNA;cell genetics, Exercise physiology;nutrition;life style, mt-Medicine
|organism=Mouse
|tissues=Skeletal muscle, Liver, Fat
|preparations=Permeabilized tissue
|couplingstates=ETS
|substratestates=CI, CII, CI&II
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=Labels, 2016-04
|additional=Labels, 2016-04
}}
}}

Revision as of 11:04, 4 April 2016

Publications in the MiPMap
Boutant M, Kulkarni SS, Joffraud M, Raymond F, Métairon S, Descombes P, Cantó C (2016) SIRT1 gain of function does not mimic or enhance the adaptations to intermittent fasting. Cell Rep 14:2068-75.

» PMID: 26923584 Open Access

Boutant M, Kulkarni SS, Joffraud M, Raymond F, Metairon S, Descombes P, Canto C (2016) Cell Rep

Abstract: Caloric restriction (CR) has been shown to prevent the onset of insulin resistance and to delay age-related physiological decline in mammalian organisms. SIRT1, a NAD(+)-dependent deacetylase enzyme, has been suggested to mediate the adaptive responses to CR, leading to the speculation that SIRT1 activation could be therapeutically used as a CR-mimetic strategy. Here, we used a mouse model of moderate SIRT1 overexpression to test whether SIRT1 gain of function could mimic or boost the metabolic benefits induced by every-other-day feeding (EODF). Our results indicate that SIRT1 transgenesis does not affect the ability of EODF to decrease adiposity and improve insulin sensitivity. Transcriptomic analyses revealed that SIRT1 transgenesis and EODF promote very distinct adaptations in individual tissues, some of which can even be metabolically opposite, as in brown adipose tissue. Therefore, whereas SIRT1 overexpression and CR both improve glucose metabolism and insulin sensitivity, the etiologies of these benefits are largely different.

Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. Keywords: SIRT1, Caloric restriction, Mitochondria


Labels: MiParea: Respiration, nDNA;cell genetics, Exercise physiology;nutrition;life style, mt-Medicine 


Organism: Mouse  Tissue;cell: Skeletal muscle, Liver, Fat  Preparation: Permeabilized tissue 


Coupling state: ETS"ETS" is not in the list (LEAK, ROUTINE, OXPHOS, ET) of allowed values for the "Coupling states" property. 

HRR: Oxygraph-2k 

Labels, 2016-04